Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19213514rdf:typepubmed:Citationlld:pubmed
pubmed-article:19213514lifeskim:mentionsumls-concept:C0043210lld:lifeskim
pubmed-article:19213514lifeskim:mentionsumls-concept:C0032460lld:lifeskim
pubmed-article:19213514lifeskim:mentionsumls-concept:C0549383lld:lifeskim
pubmed-article:19213514lifeskim:mentionsumls-concept:C0209366lld:lifeskim
pubmed-article:19213514lifeskim:mentionsumls-concept:C1268855lld:lifeskim
pubmed-article:19213514lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:19213514lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:19213514pubmed:issue12lld:pubmed
pubmed-article:19213514pubmed:dateCreated2009-2-13lld:pubmed
pubmed-article:19213514pubmed:abstractTextto evaluate the results of the use of GnRH antagonist (GnRH ant) cetrorelix and GnRH analog (GnRH a) in two matched groups of OPK ICSI patients in a retrospective matched pair analysis.lld:pubmed
pubmed-article:19213514pubmed:languagefrelld:pubmed
pubmed-article:19213514pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19213514pubmed:citationSubsetIMlld:pubmed
pubmed-article:19213514pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19213514pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19213514pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19213514pubmed:statusMEDLINElld:pubmed
pubmed-article:19213514pubmed:monthDeclld:pubmed
pubmed-article:19213514pubmed:issn0041-4131lld:pubmed
pubmed-article:19213514pubmed:authorpubmed-author:KdousMoezMlld:pubmed
pubmed-article:19213514pubmed:authorpubmed-author:ZhiouaFethiFlld:pubmed
pubmed-article:19213514pubmed:authorpubmed-author:MeriahSadokSlld:pubmed
pubmed-article:19213514pubmed:authorpubmed-author:M'SollySanaSlld:pubmed
pubmed-article:19213514pubmed:issnTypePrintlld:pubmed
pubmed-article:19213514pubmed:volume86lld:pubmed
pubmed-article:19213514pubmed:ownerNLMlld:pubmed
pubmed-article:19213514pubmed:authorsCompleteYlld:pubmed
pubmed-article:19213514pubmed:pagination1060-5lld:pubmed
pubmed-article:19213514pubmed:dateRevised2011-9-6lld:pubmed
pubmed-article:19213514pubmed:meshHeadingpubmed-meshheading:19213514...lld:pubmed
pubmed-article:19213514pubmed:meshHeadingpubmed-meshheading:19213514...lld:pubmed
pubmed-article:19213514pubmed:meshHeadingpubmed-meshheading:19213514...lld:pubmed
pubmed-article:19213514pubmed:meshHeadingpubmed-meshheading:19213514...lld:pubmed
pubmed-article:19213514pubmed:meshHeadingpubmed-meshheading:19213514...lld:pubmed
pubmed-article:19213514pubmed:meshHeadingpubmed-meshheading:19213514...lld:pubmed
pubmed-article:19213514pubmed:meshHeadingpubmed-meshheading:19213514...lld:pubmed
pubmed-article:19213514pubmed:meshHeadingpubmed-meshheading:19213514...lld:pubmed
pubmed-article:19213514pubmed:meshHeadingpubmed-meshheading:19213514...lld:pubmed
pubmed-article:19213514pubmed:meshHeadingpubmed-meshheading:19213514...lld:pubmed
pubmed-article:19213514pubmed:year2008lld:pubmed
pubmed-article:19213514pubmed:articleTitle[Use of GnRh antagonist (Cetrorelix) in controlled ovarian hyperstimulation in women with polycystic ovary disease].lld:pubmed
pubmed-article:19213514pubmed:affiliationCentre de PMA, Service de gynécologie obstétrique et de médecine de la reproduction, Hôpital Aziza Othmana de Tunis, Tunis, Tunisie.lld:pubmed
pubmed-article:19213514pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19213514pubmed:publicationTypeEnglish Abstractlld:pubmed